An observational study in COVID19 and Acute Renal Failure, sponsored by Ankara City Hospital Bilkent. Completed at 1 site in Turkey. Per ClinicalTrials.gov, last updated 2021-07-27.
Sponsored by Ankara City Hospital Bilkent · Observational
Aim of the study is to determinate the frequency of acute renal failure in COVID-19 patients, its relationship with the severity of COVID-19 disease in ICU, and the ability to take precautions against these factors.
7,638 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's enrollment of 158 is below the median of 260 across 3,135 observational studies indexed under COVID-19.
Browse COVID-19 studies →Ankara City Hospital Bilkent is the lead sponsor of 424 studies on the registry; 105 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients hospitalized in the intensive care unit diagnosed with COVID-19 will participate in the study.
Patients hospitalized in the intensive care unit diagnosed with COVID-19 will include in the study.
Exclusion Criteria:
there is no exclusion criteria
COVID-19 Patients with Acute Renal Failure in ICU
Other: BRESCİA-COVİD Respiratory Severity Scale
KDIGO acute renal failure score BRESCİA-COVID Respiratory Severity Score
KDIGO criteria
KDIGO Criteria stage 1: Increase in SCr by ≥ 0.3 mg/dL within 48 hours or increase in SCr 1.5 to 1.9 times baseline which is known or presumed to have occurred within the prior 7 days Stage 2: 2.0 to 2.9 multiplied by baseline SCr; Stage 3: 3.0 or more multiplied by baseline; increase in SCr ≥ 4.0 mg/dL; or beginning of renal replacement therapy regardless of a previous KDIGO stage.
Time frame: 6 months
BRESCIA-COVID RESPIRATORY SEVERITY SCALE (BCRSS) scores
The BCRSS score (between level 0-8) is calculated from "www.mdcalc.com/brescia-covid-respiratory-severity-scale-bcrss-algorithm" according to the severity of COVID disease , respiratory rate, PaO2 level, chest x-ray, and clinical status.
Time frame: 6 months
Plan to share: Undecided
This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ankara City Hospital Bilkent